{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0025797?format=json",
    "@type": "researchers",
    "rm:user_id": "1000074538",
    "rm:creator_id": "1000074538",
    "rm:creator_type": "myself",
    "rm:created": "2010-10-26T15:00:00Z",
    "rm:modifier_id": "1000074538",
    "rm:modifier_type": "myself",
    "rm:modified": "2022-08-20T21:43:30Z",
    "permalink": "read0025797",
    "family_name": {
        "ja": "知久馬",
        "ja-Kana": "チクマ",
        "en": "Chikuma"
    },
    "given_name": {
        "ja": "敏幸",
        "ja-Kana": "トシユキ",
        "en": "Toshiyuki"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "昭和薬科大学",
                "en": "Showa Pharmaceutical University"
            },
            "section": {
                "ja": "薬学部 薬品分析化学研究室",
                "en": "Faculty of Pharmaceutical Sciences, Showa Pharmaceutical University Department of Pharmaceutical Analytical Chemistry"
            },
            "job": {
                "ja": "教授",
                "en": "Professor"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "2208001017"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "理学博士",
                "en": "Ph. D."
            },
            "degree_institution": {
                "ja": "東京工業大学",
                "en": "Tokyo Institute of Technology"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "0192000000"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901042241629301"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901042241629301"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0025797/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0025797",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_interests/1864131",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_interests",
                    "rm:id": "1864131",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "keyword": {
                        "ja": "神経生化学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_interests/1864130",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_interests",
                    "rm:id": "1864130",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "keyword": {
                        "en": "Neuro-biochemistry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0025797/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0025797",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_areas/1301147",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_areas",
                    "rm:id": "1301147",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47040",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬理学",
                        "en": "Pharmacology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_areas/1301146",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_areas",
                    "rm:id": "1301146",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬系衛生、生物化学",
                        "en": "Pharmaceuticals - health and biochemistry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0025797/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0025797",
            "total_items": 60,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787098",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787098",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-30T20:18:18Z",
                    "paper_title": {
                        "ja": "Effects of memantine on soluble Aβ25-35 induced changes in peptidergic and glial cells in Alzheimer's disease model rat brai regions",
                        "en": "EFFECTS OF MEMANTINE ON SOLUBLE A beta(25-35)-INDUCED CHANGES IN PEPTIDERGIC AND GLIAL CELLS IN ALZHEIMER&apos;S DISEASE MODEL RAT BRAIN REGIONS"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "M. Arif"
                            },
                            {
                                "name": "T. Chikuma"
                            },
                            {
                                "name": "M.M. Ahmed"
                            },
                            {
                                "name": "M. Nakazato"
                            },
                            {
                                "name": "M.A. Smith"
                            },
                            {
                                "name": "T. Kato"
                            }
                        ],
                        "en": [
                            {
                                "name": "M. Arif"
                            },
                            {
                                "name": "T. Chikuma"
                            },
                            {
                                "name": "Md. M. Ahmed"
                            },
                            {
                                "name": "M. Nakazato"
                            },
                            {
                                "name": "M. A. Smith"
                            },
                            {
                                "name": "T. Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Soluble forms of amyloid-beta (A beta) have been considered responsible for cognitive dysfunction prior to senile plaque formation in Alzheimer&apos;s disease (AD). As its mechanism is not well understood, we examined the effects of repeated i.c.v. infusion of soluble A beta(25-35) on peptidergic system and glial cells in the pathogenesis of AD. The present study aims to investigate the protective effects of memantine on A beta(25-35)-induced changes in peptidergic and glial systems. Infusion of A beta(25-35) decreased the level of immunoreactive somatostatin (SS) and substance P (SP) in the hippocampus prior to neuronal loss or caspase activation, which is correlated with the loss of spine density and activation of inducible nitric-oxide synthase (iNOS). Biochemical experiment with peptide-degrading enzymes, prolyl oligopeptidase (POP) and endopeptidase 24.15 (EP 24.15) activities demonstrated a concomitant increase with the activation of glial marker proteins, glial fibrillary acidic protein (GFAP) and CD11b in the A beta-treated hippocampus. Double immunostaining experiments of EP 24.15 and GFAP/CD11b antibodies clearly demonstrated the co-localization of neuro peptidases with astrocytes and microglia. Treatment with memantine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist significantly attenuated A beta(25-35)-induced changes of neuropeptides, their metabolizing enzymes, glial marker proteins, and activation of iNOS. Taken together, the data implies that memantine exerts its protective effects by modulating the neuropeptide system as a consequence of suppressing the glial cells and oxidative stress in AD model rat brain regions. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2009-12",
                    "publication_name": {
                        "ja": "Neuroscience",
                        "en": "NEUROSCIENCE"
                    },
                    "volume": "164",
                    "number": "3",
                    "starting_page": "1199",
                    "ending_page": "1209",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuroscience.2009.08.063"
                        ],
                        "issn": [
                            "0306-4522"
                        ],
                        "wos_id": [
                            "WOS:000271852000029"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuroscience.2009.08.063",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000271852000029&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787097",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787097",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-30T07:13:58Z",
                    "paper_title": {
                        "en": "Inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity by cimicifugoside, a triterpenoid from Cimicifuga simplex"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Ayako Yawata"
                            },
                            {
                                "name": "Yuko Matsuhashi"
                            },
                            {
                                "name": "Hanako Kato"
                            },
                            {
                                "name": "Keiko Uemura"
                            },
                            {
                                "name": "Genjiro Kusano"
                            },
                            {
                                "name": "Junko Ito"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "Cimicifugoside, a triterpenoid isolated from Cimicifuga simplex. which has been used as a traditional Chinese medicine due to its anti-inflammatory, analgesic or anti-pyretic action, was examined for inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity. Cimicifugoside inhibited uptake of uridine, thymidine and adenosine in human leukemia U937 cells with the low nanomolar IC50 values, but did not affect that of uracil, leucine or 2-deoxyglucose at &lt;= 100 nM. Cimicifugoside analogs differentially inhibited uridine uptake in the order cimicifugoside &gt; cimicifugenin (aglycon of cimicifugoside) &gt; bugbanoside B &gt; cimicifugenin A, O-methyl cimicifugenin and bugbanoside A. Cimicifugoside had less affinity for the binding site of nitrobenzylthioinosine (typical high-affinity inhibitor of equilibrative nucleoside transporter-1) in U937 cells. K562 cells and human erythrocyte membranes compared with the prototype nucleoside transport inhibitor dipyridamole. Cimicifugoside markedly potentiated methotrexate cytotoxicity in a Culture of U937 cells and human carcinoma KB cells. Potentiation of methotrexate cytotoxicity by cimicifugoside analogs in U937 cells was in proportion to their inhibitory activity against uridine uptake. The present study demonstrates that cimicifugoside is a novel specific nucleoside transport inhibitor that displays synergistic potentiation of methotrexate cytotoxicity. (C) 2009 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2009-11",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES"
                    },
                    "volume": "38",
                    "number": "4",
                    "starting_page": "355",
                    "ending_page": "361",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejps.2009.08.011"
                        ],
                        "issn": [
                            "0928-0987"
                        ],
                        "e_issn": [
                            "1879-0720"
                        ],
                        "wos_id": [
                            "WOS:000271698900010"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejps.2009.08.011",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000271698900010&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787096",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787096",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-31T09:19:33Z",
                    "paper_title": {
                        "en": "Effect of Memantine on the Levels of Neuropeptides and Microglial Cells in the Brain Regions of Rats with Neuropathic Pain"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Katsumichi Takeda"
                            },
                            {
                                "name": "Mai Muramatsu"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Takeshi Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Neuropathic pain induced by sciatic nerve injury not only causes peripheral dysfunctions but also affects the cortical and subcortical regions of the brain. It is still unknown whether neuropathic pain could relate to behavioral and neurochemical alterations in the central nervous system. This paper deals with the effect of peripheral neuropathic pain on mechanical allodynia, neuropeptide levels, neuropeptide-degrading enzyme activities, and microglial cells in the brain regions of rats by applying chronic constriction injury, a partial sciatic nerve injury. We examined the possible protection effect on the allodynia and changes in levels of neuropeptides and microglial activation in chronic constriction injury of the rat brain by memantine. On 4 days after chronic constriction injury, the induction of mechanical allodynia was suppressed by memantine treatment. Reductions in the substance P in the hypothalamus and somatostatin in the periaqueductal gray of chronic constriction injury rat brain were reversed by memantine. This suggests the role of these neuropeptides in pain information processing in the brain. Immunohistochemical experiments revealed that the expression of CD11b, a marker protein of microglia, was increased in the hypothalamus and periaqueductal gray in the chronic constriction injury rat brain as compared with the controls, and memantine treatment could suppress the activation of microglia, suggesting the involvement of microglia in pain mechanism. The present behavioral, biochemical, and immunohistochemical studies demonstrated that peripheral neuropathic pain affects the neuropeptide levels and microglial activation in the brain regions, and these events described above may play an important role in neuropathic pain pathogenesis."
                    },
                    "publisher": {
                        "en": "HUMANA PRESS INC"
                    },
                    "publication_date": "2009-11",
                    "publication_name": {
                        "en": "JOURNAL OF MOLECULAR NEUROSCIENCE"
                    },
                    "volume": "39",
                    "number": "3",
                    "starting_page": "380",
                    "ending_page": "390",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1007/s12031-009-9224-5"
                        ],
                        "issn": [
                            "0895-8696"
                        ],
                        "wos_id": [
                            "WOS:000270739700011"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s12031-009-9224-5",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000270739700011&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787095",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787095",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-30T02:57:12Z",
                    "paper_title": {
                        "en": "Interleukin-6 Induces Prostaglandin E-2 Synthesis in Mouse Astrocytes"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Tetsuya Yoshimoto"
                            },
                            {
                                "name": "Masahiro Ohba"
                            },
                            {
                                "name": "Makoto Sawada"
                            },
                            {
                                "name": "Takeshi Kato"
                            },
                            {
                                "name": "Tomoaki Sakamoto"
                            },
                            {
                                "name": "Yukio Hiyama"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "The physiological function of interleukin-6 within the central nervous system (CNS) is complex; interleukin-6 exerts neurotrophic and neuroprotective effects and yet can also function as a mediator of inflammation, demyelination, and astrogliosis depending on the cellular context. However, the roles of interleukin-6 in astrocytes are poorly understood. In the present study, we investigated the effect of the pro-inflammatory cytokine interleukin-6 on the production of the inflammatory mediator prostaglandin E-2 in mouse astrocytes. Interleukin-6 stimulated prostaglandin E-2 production in a time-dependent fashion via a rapid and transient induction of cyclooxygenase-2 messneger RNA, followed by cyclooxygenase-2 protein synthesis. Interleukin-6 may act on the nervous system by interacting with its specific soluble interleukin-6 receptor and the signal transducer 130-kDa glycoprotein. Simultaneous treatment of astrocytes with interleukin-6 and soluble interleukin-6 receptor caused marked induction of prostaglandin E-2 synthesis, and this effect was suppressed by adding a neutralizing antibody against soluble interleukin-6 receptor. Furthermore, the mouse 130-kDa glycoprotein antibody suppressed prostaglandin E-2 formation induced by interleukin-6, as well as interleukin-6/soluble interleukin-6 receptor complexes, in a dose-dependent manner. These results indicate that interleukin-6/soluble interleukin-6 receptor complexes and the signal transducer 130-kDa glycoprotein play an important role in the regulation of cyclooxygenase-2 expression and subsequent prostaglandin E-2 formation in mouse astrocytes and that interleukin-6 is an important regulator of immune and inflammatory processes in the CNS."
                    },
                    "publisher": {
                        "en": "HUMANA PRESS INC"
                    },
                    "publication_date": "2009-09",
                    "publication_name": {
                        "en": "JOURNAL OF MOLECULAR NEUROSCIENCE"
                    },
                    "volume": "39",
                    "number": "1-2",
                    "starting_page": "175",
                    "ending_page": "184",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1007/s12031-009-9187-6"
                        ],
                        "issn": [
                            "0895-8696"
                        ],
                        "e_issn": [
                            "1559-1166"
                        ],
                        "wos_id": [
                            "WOS:000269903800019"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s12031-009-9187-6",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000269903800019&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787094",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787094",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-09T03:58:20Z",
                    "paper_title": {
                        "en": "Up-regulation of hepatic heme oxygenase-1 expression by locally induced interleukin-6 in rats administered carbon tetrachloride intraperitoneally"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Kenzaburo Yamaji"
                            },
                            {
                                "name": "Yosuke Ochiai"
                            },
                            {
                                "name": "Ken-ichi Ohnishi"
                            },
                            {
                                "name": "Ayako Yawata"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "We previously reported that interleukin-6 (IL-6) was locally produced in the early period after intraperitoneal (i.p.) or subcutaneous carbon tetrachloride (CCl4) administration, but not after oral (p.o.) administration. In the present study, we focused on the up-regulation of stress-inducible proteins induced by IL-6 after i.p. CCl4 administration. The expression of heme oxygenase-1 (HO-1) (EC 1.14.99.3) mRNA and protein were induced more in rats administered CCl4 via the i.p. route, compared with the p.o. route; however, expression of heat shock protein (HSP) 72 and HSP90 mRNA were increased to similar extents in both experimental groups. The induction of HO-1 mRNA and protein after i.p. CCl4 administration were significantly reduced after pretreatment with anti-rat IL-6 antibody. Activation of the signal transducer and activator of transcription factor 3 (STAT3), which promotes HO-1 expression, peaked together with plasma levels of IL-6 after i.p. CCl4 administration, suggesting that hepatic HO-1 expression was increased by IL-6 via the Janus kinase/STAT3 pathway. The present data indicate that hepatic HO-1 is up-regulated by endogenously produced IL-6, in addition to its up-regulation by heme derived from cytochrome P450 which has already been reported in rats administered LP. CCl4. The up-regulation of hepatic HO-1 expression may reduce the tissue injury to livers caused by CCl4. (C) 2008 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2008-07",
                    "publication_name": {
                        "en": "TOXICOLOGY LETTERS"
                    },
                    "volume": "179",
                    "number": "3",
                    "starting_page": "124",
                    "ending_page": "129",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.toxlet.2008.04.012"
                        ],
                        "issn": [
                            "0378-4274"
                        ],
                        "e_issn": [
                            "1879-3169"
                        ],
                        "wos_id": [
                            "WOS:000258042000003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.toxlet.2008.04.012",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000258042000003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787093",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787093",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-07T06:56:40Z",
                    "paper_title": {
                        "en": "Interleukin-6 production by peritoneal inflammatory factors in mesothelial cells and its regulation by rats administered carbon tetrachloride intraperitoneally"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Kenzaburo Yamaji"
                            },
                            {
                                "name": "Ken-ichi Ohnishi"
                            },
                            {
                                "name": "Ryii Zuinen"
                            },
                            {
                                "name": "Yosuke Ochial"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "We previously reported that a high level of interleukin-6 (IL-6), which is protective against CCl4-induced hepatotoxicity, is produced in the peritoneal cavity in the early period after ip carbon tetrachloride (CCl4) administration. The objective of this study was to identify the tissues and cells involved in IL-6 production and clarify the mechanisms underlying its regulation. IL-6 mRNA levels increased significantly in the serous membranes of the mesentery and peritoneum, but not in the parenchymal organs including liver, kidney and spleen, 3 It after ip CCl4 administration. Peritoneal mesothelial cells (PMCs), a major cell population in serous membranes, were isolated from rat peritoneal walls by trypsin digestion and cultured with peritoneal exudate fluid (PEF) from CCl4-administered rats. PMCs produced a high level of IL-6 in the presence of PEF recovered 0.5 It after ip CCl4 administration. Analyses of PEF revealed that the levels of prostaglandin E-2 (PGE(2)), histamine, IL-1 alpha, IL-1 beta and tumor necrosis factor-alpha (TNF-alpha) increased immediately after iP CCl4 administration. These inflammatory factors, except for histamine, stimulated IL-6 production to varying degrees, in the following order: IL-1 alpha &gt; IL-1 beta &gt; TNF-alpha &gt;&gt; PGE(2) In summary, the present study indicates that the high level of IL-6 observed in the rat peritoneal cavity after ip CCl4 administration is at least partially produced by PMCs stimulated cooperatively with IL-1 alpha, IL-1 beta, TNF-alpha and PGE(2). These inflammatory factors may be released from tissues or cells either stimulated or injured directly by CCl4. (c) 2007 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ACADEMIC PRESS INC ELSEVIER SCIENCE"
                    },
                    "publication_date": "2008-01",
                    "publication_name": {
                        "en": "TOXICOLOGY AND APPLIED PHARMACOLOGY"
                    },
                    "volume": "226",
                    "number": "1",
                    "starting_page": "38",
                    "ending_page": "45",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.taap.2007.08.014"
                        ],
                        "issn": [
                            "0041-008X"
                        ],
                        "wos_id": [
                            "WOS:000252235600005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.taap.2007.08.014",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000252235600005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787092",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787092",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-11T01:14:44Z",
                    "paper_title": {
                        "en": "4-hydroxy-2-nonenal-modified glyceraldehyde-3-phosphate dehydrogenase is degraded by cathepsin G"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yukihiro Tsuchiya"
                            },
                            {
                                "name": "Yasutaka Okuno"
                            },
                            {
                                "name": "Kayoko Hishinuma"
                            },
                            {
                                "name": "Asami Ezaki"
                            },
                            {
                                "name": "Go Okada"
                            },
                            {
                                "name": "Mitsune Yamaguchi"
                            },
                            {
                                "name": "Toshlyuki Chikuma"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "Degradation of oxidized or oxidatively modified proteins is an essential part of the antioxidant defenses of cells. 4-Hydroxy-2-nonenal (HNE), a major reactive aldehyde formed by lipid peroxidation, causes many types of cellular damage. It has been reported that HNE-modified proteins are degraded by the ubiquitin-proteasome pathway or, in some cases, by the lysosomal pathway. However, our previous studies using U937 cells showed that HNE-modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is degraded by an enzyme that is sensitive to a serine protease inhibitor, diisopropyl fluorophosphate (DFP), but not a proteasome inhibitor, MG-132, and that its degradation is not catalyzed in the acidic pH range where lysosomal enzymes are active. In the present study, we purified an HNE-modified GAPDH-degrading enzyme from a U937 cell extract to a final active fraction containing two proteins of 28 kDa (P28) and 27 kDa (P27) that became labeled with [H-3]DFP. Using peptide mass fingerprinting and a specific antibody, P28 and P27 were both identified as cathepsin G. The degradation activity was inhibited by cathepsin G inhibitors. Furthermore, a cell extract from U937 cells transfected with a cathepsin G-specific siRNA hardly degraded HNE-modified GAPDH. These results suggest that cathepsin G plays a role in the degradation of HNE-modified GAPDH. (C) 2007 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2007-12",
                    "publication_name": {
                        "en": "FREE RADICAL BIOLOGY AND MEDICINE"
                    },
                    "volume": "43",
                    "number": "12",
                    "starting_page": "1604",
                    "ending_page": "1615",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.freeradbiomed.2007.08.024"
                        ],
                        "issn": [
                            "0891-5849"
                        ],
                        "wos_id": [
                            "WOS:000251670500005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.freeradbiomed.2007.08.024",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000251670500005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787091",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787091",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-12T17:22:45Z",
                    "paper_title": {
                        "ja": "Involvement of the protein kinase Cγ isoform in development of tolerance to nitrous oxide-induced antinociception in mice",
                        "en": "Involvement of the protein development of tolerance antinociception in mice"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "Y. Matsushita"
                            },
                            {
                                "name": "M. Ishikawa"
                            },
                            {
                                "name": "K. Abe"
                            },
                            {
                                "name": "I. Utsunomiya"
                            },
                            {
                                "name": "T. Chikuma"
                            },
                            {
                                "name": "H. Hojo"
                            },
                            {
                                "name": "K. Hoshi"
                            },
                            {
                                "name": "R.M. Quock"
                            },
                            {
                                "name": "K. Taguchi"
                            }
                        ],
                        "en": [
                            {
                                "name": "Y. Matsushita"
                            },
                            {
                                "name": "M. Ishikawa"
                            },
                            {
                                "name": "K. Abe"
                            },
                            {
                                "name": "I. Utsunomiya"
                            },
                            {
                                "name": "T. Chikuma"
                            },
                            {
                                "name": "H. Hojo"
                            },
                            {
                                "name": "K. Hoshi"
                            },
                            {
                                "name": "R. M. Quock"
                            },
                            {
                                "name": "K. Taguchi"
                            }
                        ]
                    },
                    "description": {
                        "en": "Prolonged exposure to nitrous oxide (N2O) results in development of acute tolerance to its antinociceptive effect. Cross-tolerance to N2O-induced antinociception is also observed in morphine-tolerant animals. Despite increasing evidence of tolerance development to N2O-induced antinociception, the details of the mechanisms that underlie this tolerance remain unknown. The present study was conducted to investigate the involvement of brain protein kinase C (PKC) isoform in these two types of tolerance to N2O-induced antinociception in mice. Prolonged exposure (41 min in total, including 30 min pre-exposure and 11 min of antinociceptive testing) to 70% N2O produced a reduction in N2O-induced anti nociception, indicating development of acute tolerance. The prolonged exposure to 70% N2O caused an activation of PKC gamma isoform in the brain, but not the PKC epsilon isoform. Pretreatment with a PKC gamma-rantisense oligonucleotide but not the corresponding mismatch oligonucleotide (i.c.v.) prevented the development of acute tolerance to N2O-induced anti nociception. Chronic morphine treatment (10 mg/kg, s.c., b.i.d. for 5 days) resulted in development of tolerance to morphine-induced antinociception and cross-tolerance to N2O-induced anti nociception. The development of tolerance to morphine and cross-tolerance to N2O were both inhibited by pretreatment with PKC inhibitor, chelerythrine (11 nmol, i.c.v.). Morphine-tolerant mice showed an activation of PKC within the brain, which was suppressed by pretreatment with chelerythrine (1 nmol, i.c.v.). Thus, activation of brain PKC, in particular, the PKC gamma isoform, appears to play an important role in the development of both acute tolerance and cross-tolerance to N2O-induced antinociception in mice. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2007-08",
                    "publication_name": {
                        "ja": "Neuroscience",
                        "en": "NEUROSCIENCE"
                    },
                    "volume": "148",
                    "number": "2",
                    "starting_page": "541",
                    "ending_page": "547",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuroscience.2007.06.019"
                        ],
                        "issn": [
                            "0306-4522"
                        ],
                        "wos_id": [
                            "WOS:000249638100021"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuroscience.2007.06.019",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000249638100021&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787090",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787090",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-13T01:48:12Z",
                    "paper_title": {
                        "en": "Early induced, high-level interleukin-6 expression in the rat peritoneal cavity into which a hepatotoxicant carbon tetrachloride was administered"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Ryoji Zuinen"
                            },
                            {
                                "name": "Kenzaburo Yamaji"
                            },
                            {
                                "name": "Miho Aoki"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "IL-6 induction depending on the mode of carbon tetrachloride (CCl4) administration was investigated in rats. After the intraperitoneal (i.p.) administration of CCl4 in 50% corn oil at 1.0 ml/kg body weight, IL-6 level markedly increased in plasma and peaked at 4 h. TNF-alpha and IL-1 beta levels gradually increased, reaching the maximum at 24 h. IL-10 level transiently peaked at 4 h and then decreased, but later further increased, reaching the second peak at 24h. Plasma alanine aminotransferase (ALT) and sorbitol dehydrogenase (SDH) activities peaked at 24 h. As the vehicle-to-CCl4 ratio increased, the level of IL-6 decreased and the activities of ALT and SDH increased. After oral CCl4 administration, IL-6 was not significantly detected. IL-6 level in peritoneal exudate fluid (PEF) increased simultaneously with plasma IL-6 level after i.p. CCl4 administration, but the total amount of PEF IL-6 was 37-fold as much as that of plasma IL-6, in contrast to the result that the total amount of plasma IL-6 was 19-fold as much as that of PEF IL-6 after i.p. lipopolysaccharide administration. These results suggest that i.p. administration Of CCl4 dissolved in a small amount of vehicle selectively induces a high production of IL-6 in the peritoneal cavity early after the administration. Since IL-6 is a protective cytokine against hepatotoxicity, its induction should be taken into consideration during analysis of data obtained using the CCl4-induced liver injury model. (C) 2007 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2007-04",
                    "publication_name": {
                        "en": "TOXICOLOGY LETTERS"
                    },
                    "volume": "170",
                    "number": "1",
                    "starting_page": "42",
                    "ending_page": "48",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.toxlet.2007.02.003"
                        ],
                        "issn": [
                            "0378-4274"
                        ],
                        "wos_id": [
                            "WOS:000246320400005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.toxlet.2007.02.003",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000246320400005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787089",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787089",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-12T14:20:18Z",
                    "paper_title": {
                        "en": "Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Mohammad Arif"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Md. Mahiuddin Ahmed"
                            },
                            {
                                "name": "Shunsuke Yoshida"
                            },
                            {
                                "name": "Takeshi Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, produces neurotoxicity in adult rodent brain, and causes schizophrenia-like psychosis and cognitive dysfunction. Since neuropeptides and neuropeptide-degrading enzymes play important roles in cognitive function, we examined whether or not MK-801-induced schizophrenia-like psychosis is co-related with the changes of these enzymes in rat brain regions. In the present study, we investigated the effect of systemic treatment with MK-801 (0.5 mg/kg) on neuropeptide-degrading enzymes, prolyl oligopeptidase (POP) and thimet oligopeptidase (EP 24.15), and glial marker proteins GFAP and CD11b in rat brain regions. The levels of POP and EP 24.15 activities increased significantly three days after treatment with MK-801 in the posterior cingulate/retrosplenial cortices (PC/RSC). Since atypical neuroleptic clozapine but not typical neuroleptic haloperidol prevents the MK-801-induced schizophrenia-like symptoms, we further examined the pretreated effects of the neuroleptics. Clozapine, but not haloperidol, significantly attenuated MK-801-induced changes in the levels of the neuropeptide-degrading enzymes. Immunohistochemical studies on GFAP and CD11b showed the increase in the PC/RSC of MK-801-treated rat brain and the pretreatment with clozapine suppressed these changes. Double immunostain experiments of EP 24.15 and GFAP antibodies demonstrated some co-localization of the neuropeptidase with astrocytes. The present findings suggest that change of neuropeptidases in the brain is in part correlated with changes of glial cells, and may play an important role in the control of schizophrenia-like psychotic disorders. (c) 2006 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2007-02",
                    "publication_name": {
                        "en": "NEUROSCIENCE RESEARCH"
                    },
                    "volume": "57",
                    "number": "2",
                    "starting_page": "248",
                    "ending_page": "258",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10021188940"
                        ],
                        "doi": [
                            "10.1016/j.neures.2006.10.021"
                        ],
                        "issn": [
                            "0168-0102"
                        ],
                        "pm_id": [
                            "17141345"
                        ],
                        "wos_id": [
                            "WOS:000244575200010"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10021188940",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neures.2006.10.021",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/17141345",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000244575200010&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787088",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787088",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-11T12:03:36Z",
                    "paper_title": {
                        "en": "Axonal transports of tripeptidyl peptidase II in rat sciatic nerves"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Maki Shimizu"
                            },
                            {
                                "name": "Yukihiro Tsuchiya"
                            },
                            {
                                "name": "Takeshi Kato"
                            },
                            {
                                "name": "Hiroshi Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "Axonal transport of tripeptidyl peptidase II, a putative cholecystokinin inactivating serine peptidase, was examined in the proximal, middle, and distal segments of rat sciatic nerves using a double ligation technique. Enzyme activity significantly increased not only in the proximal segment but also in the distal segment 12-72 h after ligation, and the maximal enzyme activity was found in the proximal and distal segments at 72 h. Western blot analysis of tripeptidyl peptidase H showed that its immunoreactivities in the proximal and distal segments were 3.1- and 1.7-fold higher than that in the middle segment. The immunohistochemical analysis of the segments also showed an increase in immunoreactive tripeptidyl peptidase II level in the proximal and distal segments in comparison with that in the middle segment, indicating that tripeptidyl peptidase II is transported by anterograde and retrograde axonal flow. The results suggest that tripeptidyl peptidase II may be involved in the metabolism of neuropeptides in nerve terminals or synaptic clefts. (c) 2006 Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2007-01",
                    "publication_name": {
                        "en": "NEUROCHEMISTRY INTERNATIONAL"
                    },
                    "volume": "50",
                    "number": "1",
                    "starting_page": "236",
                    "ending_page": "242",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuint.2006.08.010"
                        ],
                        "issn": [
                            "0197-0186"
                        ],
                        "wos_id": [
                            "WOS:000243645000027"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuint.2006.08.010",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000243645000027&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787087",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787087",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-18T11:16:48Z",
                    "paper_title": {
                        "en": "Clozapine but not haloperidol suppresses the changes in the levels of neuropeptides in MK-801-treated rat brain regions"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Mohammad Arif"
                            },
                            {
                                "name": "Md. Mahiuddin Ahmed"
                            },
                            {
                                "name": "Yukiko Kumabe"
                            },
                            {
                                "name": "Hajime Hoshino"
                            },
                            {
                                "name": "Toshiyuki Chikuma"
                            },
                            {
                                "name": "Takeshi Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Noncompetitive NMDA receptor antagonist (+)MK-801 is known to induce neurotoxicity and schizophrenia-like symptomatology where atypical neuroleptic clozapine is effective in contrast to typical neuroleptic, haloperidol. Although neuropeptides are implicated in memory and cognition, their roles in schizophrenia are not well understood. In the present study, we therefore examined the possible roles of neuropeptides, cholecystokinin (CCK) and somatostatin (SS) in the posterior cingulate/retrosplenial cortices (PC/RSC), frontal cortex, and hippocampus of a MK-801-induced schizophrenia-like model rat brain. This study further investigated the pretreated effect of atypical versus typical neuroleptics on the peptidergic system. SS mRNA and peptide levels significantly decreased in the PC/RSC and hippocampus but not in the frontal cortex 3 days after 0.5 mg/kg MK-801 treatment whereas CCK mRNA and peptide levels significantly decreased in all of the brain regions examined. Pretreatment with clozapine but not haloperidol completely recovered the changes in both mRNA and peptide levels of SS and CCK in those brain regions. These data suggest that peptidergic system in the brain presumably plays an important role in the control of negative schizophrenia. (c) 2006 Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2006-08",
                    "publication_name": {
                        "en": "NEUROCHEMISTRY INTERNATIONAL"
                    },
                    "volume": "49",
                    "number": "3",
                    "starting_page": "304",
                    "ending_page": "311",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuint.2006.01.016"
                        ],
                        "issn": [
                            "0197-0186"
                        ],
                        "wos_id": [
                            "WOS:000239212400012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuint.2006.01.016",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000239212400012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787086",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787086",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T22:14:56Z",
                    "paper_title": {
                        "en": "Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "MM Ahmed"
                            },
                            {
                                "name": "M Arif"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "T Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "The regulatory mechanisms of neuropeptide-metabolizing enzymes often play a critical role in the pathogenesis of neuronal damage. A systemic administration of pentylenetetrazol (PTZ), an antagonist of GABA(A) receptor ion channel binding site, causes generalized epilepsy in an animal model. In the present study, we examined the involvement of prolyl oligopeptidase (POP), thimet oligopeptidase/neurolysin (EP 24.15/16) and glial proteins in PTZ-treated rat brain regions, and the suppressive effect of MK-801, a non-competitive NMDA receptor antagonist, pretreatment for their proteins. The activity of POP significantly decreased in the hippocampus at 30 min and 3 h, and in the frontal cortex at 3 h. after PTZ treatment, and pretreatment with MK-801 recovered the activity in the cortex at 3 h. The activity of EP 24.15/16 significantly decreased in the hippocampus at,3 h and I day, and in the cortex at 3 h after the PTZ administration, whereas pretreatment with MK-801 recovered the change of the activity. The Western blot analysis of EP 24.15 showed significant decrease of the protein level in the hippocampus 3 h after the PTZ treatment, whereas pretreatment with MK-801 recovered. The expression of GFAP and CD11b immunohistochemically increased in the hippocampus of the PTZ-treated rat as compared with controls.. Pretreatment with MK-801 also recovered the GFAP and CD11b expression. These data suggest that PTZ-induced seizures of the rats cause indirect activation of glutamate NNMA receptors, then decrease POP and EP 24.15/16 enzyme activities and EP 24.15 immunoreactivity in the neuronal cells of the hippocampal formation. We speculate that changes of those peptidases in the brain may be related to the levels of the neuropeptides regulating PTZ-induced seizures. (c) 2005 Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2005-09",
                    "publication_name": {
                        "en": "NEUROCHEMISTRY INTERNATIONAL"
                    },
                    "volume": "47",
                    "number": "4",
                    "starting_page": "248",
                    "ending_page": "259",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuint.2005.04.025"
                        ],
                        "issn": [
                            "0197-0186"
                        ],
                        "wos_id": [
                            "WOS:000230857900003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuint.2005.04.025",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000230857900003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787085",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787085",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-09T03:13:19Z",
                    "paper_title": {
                        "en": "Degradation of glyceraldehyde-3-phosphate dehydrogenase triggered by 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Y Tsuchiya"
                            },
                            {
                                "name": "M Yamaguchi"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "H Hojo"
                            }
                        ]
                    },
                    "description": {
                        "en": "Lipid peroxidation products such as 4-hydroxy-2-nonenal (HNE) may be responsible for various pathophysiological events under oxidative stress, since they injure cellular components Such as proteins and DNA. Glyceraldeliyde-3-pliosphate dehydrogenase (GAPDH), which is a key enzyme of glycolysis and has been reported to be a multifunctional enzyme, is one of the enzymes inhibited by HNE. Previous studies showed that GAPDH is degraded when incubated with acetylleucine chloromethyl ketone (ALCK), resulting in the liberation of a 23-kDa fragment. In this study, we examined whether GAPDH incubated with HNE or other aldehydes of lipid peroxidation products are degraded similarly to that with ALCK. The U937 cell extract was incubated with these aldehydes at 37 degrees C and analyzed by Western blotting using anti-GAPDH antibodies. Incubation with HNE or 4-hydroxy-2-hexenal (HHE) decreased GAPDH activity and GAPDH protein level, and increased the 23-kDa fragment, in time- and dose-dependent manners, but that with other aldehydes did not. Gel filtration using the Superose 6 showed that the GAPDH-degrading activity was eluted in higher molecular fractions than proteasome activity. The enzyme activity was detected at the basic range of pH and inhibited by serine protease inhibitors, diisopropyl fluorophosphate and phenylmethylsulfonyl fluoride, but not by other protease inhibitors including a proteasome inhibitor, MG-132, and a tripeptidyl peptidase II (TPP II) inhibitor, AAF-CMK. These results suggest that GAPDH modified by HNE and H HE is degraded by a giant serine protease, releasing the 23-kDa fragment, not by proteasome or TPP II. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2005-06",
                    "publication_name": {
                        "en": "ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS"
                    },
                    "volume": "438",
                    "number": "2",
                    "starting_page": "217",
                    "ending_page": "222",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "80017387700"
                        ],
                        "doi": [
                            "10.1016/j.abb.2005.04.015"
                        ],
                        "issn": [
                            "0003-9861"
                        ],
                        "pm_id": [
                            "15907785"
                        ],
                        "wos_id": [
                            "WOS:000229918500012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80017387700",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.abb.2005.04.015",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15907785",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000229918500012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787083",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787083",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-26T19:16:43Z",
                    "paper_title": {
                        "en": "A highly sensitive and stable detection of acetylcholine by HPLC-osmium-horseradish peroxidase redox polymer electrode coated on a gold radial flow ring disk"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Yamamoto"
                            },
                            {
                                "name": "K Sato"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "T Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "To detect a low level of acetylcholine (Ach) output in the dialysate of rat frontal cortex, osmium-peroxidase redox polymer modified gold-ring disk electrode (Os-HRP-RDE) was fabricated in high-performance liquid chromatography (HPLC)-electrochemical detection (ECD). In comparison with platinum electrode, the sensitivity of acetylcholine detection by Os-HRP-RDE was stable during a day, the coefficient of variation was 0.95%, and the decrease of the sensitivity for 1 week was 5.4%. The Os-HR-P-RDE could detect lower than 3 fmol of acetylcholine. The present technique, in the absence of acetylcholinesterase (AchE) inhibitor, is useful to facilitate physiological investigations of cholinergic neuronal activity in the brain. (C) 2004 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2004-09",
                    "publication_name": {
                        "en": "ANALYTICA CHIMICA ACTA"
                    },
                    "volume": "521",
                    "number": "2",
                    "starting_page": "209",
                    "ending_page": "213",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "80016853264"
                        ],
                        "doi": [
                            "10.1016/j.aca.2004.06.062"
                        ],
                        "issn": [
                            "0003-2670"
                        ],
                        "wos_id": [
                            "WOS:000223611500012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80016853264",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.aca.2004.06.062",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000223611500012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787081",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787081",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-27T21:42:33Z",
                    "paper_title": {
                        "en": "Improved determination of bovine glutaminyl cyclase activity using precolumn derivatization and reversed-phase high-performance liquid chromatography with ultraviolet detection"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "K Taguchi"
                            },
                            {
                                "name": "M Yamaguchi"
                            },
                            {
                                "name": "H Hojo"
                            },
                            {
                                "name": "T Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "A sensitive. rapid and reproducible assay for the determination of glutaminyl cyclase activity is reported. This method is based on the monitoring of the absorption of L-pyroglutamic acid beta-naphthylamide at 235 nm, enzymatically formed from the substrate L-glutaminyl-beta-naphthylamide, after separation by high-performance liquid chromatography using a C-18 reversed-phase column by isocratic elution. The detection limit of this method is at a level as low as 0.08 nmol/ml and, the time consumed for analysis is &lt;6.5 min per sample for separation and quantification. The optimum pH for glutaminyl cyclase activity was 8.0-8.5. The K-m and V-max values were 100.2 +/- 2.9 muM and 332 +/- 21.7 pmol/(h mug protein), respectively, with the use of enzyme extract obtained from bovine pituitary. Glutaminyl cyclase activity was strongly inhibited by zinc(II) ion and 1,10-phenanthroline. By using this assay, the stimulatory effect of bacterial lipopolysaccharide on this enzyme activity was observed in macrophage cell line RAW 264.7. Our newly developed assay would be useful for clarification of the physiological role of this enzyme. (C) 2004 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2004-07",
                    "publication_name": {
                        "en": "JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES"
                    },
                    "volume": "806",
                    "number": "2",
                    "starting_page": "113",
                    "ending_page": "118",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10016552110"
                        ],
                        "doi": [
                            "10.1016/j.jchromb.2004.03.040"
                        ],
                        "issn": [
                            "1570-0232"
                        ],
                        "pm_id": [
                            "15171919"
                        ],
                        "wos_id": [
                            "WOS:000221945700005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10016552110",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.jchromb.2004.03.040",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15171919",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000221945700005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787084",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787084",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "paper_title": {
                        "ja": "Preparation of monoclonal antibodies reactive to a hallucinogenic drug, psilocin"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "M. Yamaguchi"
                            },
                            {
                                "name": "T. Saito"
                            },
                            {
                                "name": "Y. Horiguchi"
                            },
                            {
                                "name": "K. Ogawa"
                            },
                            {
                                "name": "Y. Tsuchiya"
                            },
                            {
                                "name": "K. Hishimuma"
                            },
                            {
                                "name": "T. Chikuma"
                            },
                            {
                                "name": "Y. Makino"
                            },
                            {
                                "name": "H. Hojo"
                            }
                        ]
                    },
                    "publication_date": "2004",
                    "publication_name": {
                        "ja": "J. Health Sci."
                    },
                    "volume": "50",
                    "number": "6",
                    "starting_page": "600",
                    "ending_page": "604",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1248/jhs.50.600"
                        ],
                        "issn": [
                            "1344-9702",
                            "1347-5207"
                        ],
                        "cinii_na_id": [
                            "110003666009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/jhs.50.600",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003666009",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787082",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787082",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-27T11:41:14Z",
                    "paper_title": {
                        "en": "Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated Alzheimer's disease model"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "MM Ahmed"
                            },
                            {
                                "name": "H Hoshino"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "M Yamada"
                            },
                            {
                                "name": "T Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "It has been implicated that glia activation plays a critical role in the progression of Alzheimer's disease (AD). However, the precise mechanism of glia activation is not clearly understood yet. In our present studies, we confirmed our previous results where change the levels of neuropeptides and peptidases in ibotenic acid (IBO) infusion into the rat nucleus basalis magnocellularis, an animal model of AD. Furthermore, we extended our study to investigate a possible protection effect of co-administration on the changes of neuropeptides, and neuronal and glial cells in IBO-infused rat brain by memantine treatment. The levels of substance P and somatostatin were decreased in the striatum and frontal cortex 1 week after IBO infusion, and recovered to the control level by memantine treatment, indicating the involvement of neuropeptides in AD pathology. Furthermore, the immunohistochemical and enzymatic studies of GFAP and CD 11b, and peptidylarginine deiminase, markers of glia, in the striatum and frontal cortex showed the increase in IBO-treated rat brain as compared with controls, while co-administration of memantine and IBO no increase of astrocytes and microglia activation was observed. The present biochemical and immunohistochemical results suggest that glia activation might play an important role to the pathology of AD, and correlate with the changes of neuropeptide levels in AD brain that is recovered by memantine treatment. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2004",
                    "publication_name": {
                        "en": "NEUROSCIENCE"
                    },
                    "volume": "126",
                    "number": "3",
                    "starting_page": "639",
                    "ending_page": "649",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuroscience.2004.04.024"
                        ],
                        "issn": [
                            "0306-4522"
                        ],
                        "wos_id": [
                            "WOS:000222346400012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuroscience.2004.04.024",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000222346400012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787076",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787076",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-30T11:53:21Z",
                    "paper_title": {
                        "en": "Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Abe"
                            },
                            {
                                "name": "K Taguchi"
                            },
                            {
                                "name": "M Kato"
                            },
                            {
                                "name": "Utsunomiya, I"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "H Hojyo"
                            },
                            {
                                "name": "T Miyatake"
                            }
                        ]
                    },
                    "description": {
                        "en": "The present study investigated the role of muscarinic receptor subtypes in the nucleus reticularis gigantocellularis/nucleus reticularis gigantocellularis alpha of the rat rostral ventrolateral medulla in morphine-induced antinociception. The antinociceptive effects of morphine were evoked by systemic administration or microinjection into the nucleus reticularis gigantocellularis/nucleus reticularis gigantocellularis alpha. Administration of morphine produced antinociception for hot plate and tail immersion responses to noxious heat stimuli. These effects were antagonized by prior exposure to naloxone and inhibited by mecamylamine pretreatment. Morphine-induced antinociception was significantly inhibited by atropine in a dose-dependent manner. Muscarinic toxin-1 and pirenzepine inhibited morphine-induced antinociception for both the hot plate and tail immersion tests. At a dose of 5 nmol/site, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) also inhibited morphine-induced antinociception, although low doses of this drug did not significantly affect hot plate test response latency when morphine was systemically administered. These results suggest that the antinociceptive effects induced by morphine in part involve the muscarinic M-1 and M-3 receptors of the rat nucleus reticularis gigantocellularis/nucleus reticularis gigantocellularis alpha. (C) 2003 Elsevier Science B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2003-04",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACOLOGY"
                    },
                    "volume": "465",
                    "number": "3",
                    "starting_page": "237",
                    "ending_page": "249",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0014-2999(03)01494-8"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "wos_id": [
                            "WOS:000182023000005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0014-2999(03)01494-8",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000182023000005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/misc/16787077",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0025797/misc",
                    "rm:id": "16787077",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-30T01:07:50Z",
                    "paper_title": {
                        "en": "Anterograde axonal transport of endopeptidase 24.15 in rat sciatic nerves"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Yamamoto"
                            },
                            {
                                "name": "T Chikuma"
                            },
                            {
                                "name": "A Yamashita"
                            },
                            {
                                "name": "M Yamaguchi"
                            },
                            {
                                "name": "H Hojo"
                            },
                            {
                                "name": "Y Ozeki"
                            },
                            {
                                "name": "M Ahmed"
                            },
                            {
                                "name": "T Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Axonal transport of endopeptidase 24.15 (EP24.15), a putative neuropeptide degrading-enzyme, was examined in the proximal, middle, and distal segments of rat sciatic nerves using a double ligation technique. At 48 h after ligation, a significant amount of the axonal transport of EP24.15 activity was found in the proximal segment, while axonal transport of deamidase activity, a lysosomal enzyme, increased in both proximal and distal segments. Western blot analysis of EP24.15 showed that EP24.15 immunoreactivity in the proximal segment was 1.8-fold higher than that in the middle segment. The immunohistochemical analysis of the segments also showed an increase in the immunoreactive EP24.15 in the proximal segment in comparison with that in the middle segment. In the distal segment, no axonal transport of EP24.15 was found in all methods examined, indicating that EP24.15 is mainly transported by an anterograde axonal flow. These observations suggest that EP24.15 may be involved in the metabolism of neuropeptides in nerve terminals or synaptic clefts. (C) 2003 Elsevier Science Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2003-02",
                    "publication_name": {
                        "en": "NEUROCHEMISTRY INTERNATIONAL"
                    },
                    "volume": "42",
                    "number": "3",
                    "starting_page": "231",
                    "ending_page": "237",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0197-0186(02)00092-X"
                        ],
                        "issn": [
                            "0197-0186"
                        ],
                        "wos_id": [
                            "WOS:000179792700005"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0197-0186(02)00092-X",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000179792700005&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0025797/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0025797",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0025797/association_memberships/2032886",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0025797/association_memberships",
                    "rm:id": "2032886",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本神経化学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/association_memberships/2032885",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0025797/association_memberships",
                    "rm:id": "2032885",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本生化学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/association_memberships/2032884",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0025797/association_memberships",
                    "rm:id": "2032884",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0025797/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0025797",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_projects/2960551",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_projects",
                    "rm:id": "2960551",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "research_project_title": {
                        "ja": "精神・神経疾患の病態と治療"
                    },
                    "from_date": "2009",
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "description": {
                        "ja": "統合失調症における神経ペプチドの変動と神経ペプチド代謝酵素の関与に関する研究"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0025797/research_projects/2960550",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0025797/research_projects",
                    "rm:id": "2960550",
                    "rm:user_id": "1000074538",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000074538",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-26T15:00:00Z",
                    "rm:modifier_id": "1000074538",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-26T15:00:00Z",
                    "research_project_title": {
                        "en": "neuropsychiatric disorders and therapy"
                    },
                    "from_date": "2009",
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}